After 5-Year Winning Streak, Xarelto Makers Settle Personal Injury Suits

Bayer and Johnson & Johnson agree to resolve approximately 25,000 claims in federal and state courts for $775m, almost 13% of Xarelto's 2018 sales.

Johor,Malaysia-November 05,2017. Xarelto, medication to reduce stroke and blood clot by Bayer Healthcare. - Image

More from Legal & IP

More from Pink Sheet